Oak Hill Bio Announces Publication of Rugonersen Phase 1 Study Results in Nature Medicine
Oak Hill Bio’s Phase 1 TANGELO study results, published in Nature Medicine, show improvements in brain activity and development for children with Angelman syndrome on rugonersen.